Post Acute Pancreatitis Pancreatic Exocrine Insufficiency
PAPPEI
PAPPEI: Post Acute Pancreatitis Pancreatic Exocrine Insufficiency
1 other identifier
observational
196
1 country
3
Brief Summary
This study is a proposed a comprehensive prospective assessment of exocrine pancreatic insufficiency (EPI), nutritional status, and quality of life (QOL) during the early re-feeding phase, at 3 months, and 12 months following an AP attack.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2017
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2017
CompletedFirst Posted
Study publicly available on registry
February 24, 2017
CompletedStudy Start
First participant enrolled
June 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJuly 16, 2024
July 1, 2024
5.6 years
February 2, 2017
July 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Exocrine pancreatic insufficiency at 12 months
Fecal elastase-1 levels EPI below 200 mcg/g stool,
12 months
Study Arms (1)
Patients after acute pancreatitis
Such patients will be followed and assessed for the development of Exocrine Pancreatic Insufficiency. 'No intervention, this is an observational study.
Interventions
Assessment for exocrine pancreatic insufficiency
Eligibility Criteria
Men and women, at least 18 years of age, admitted at the University of Pittsburgh Medical Center with an AP attack defined as the presence of 2 or more of the following criteria: * Abdominal pain consistent with the disease, * Serum amylase and/or lipase greater than three times the upper limit of normal, and or * Characteristic findings from abdominal imaging (i.e. demonstrating pancreatic edema, peripancreatic fat stranding or complications or acute pancreatitis)
You may qualify if:
- Men and women, at least 18 years of age, admitted at the University of Pittsburgh Medical Center with an AP attack defined as the presence of 2 or more of the following criteria:
- Abdominal pain consistent with the disease,
- Serum amylase and/or lipase greater than three times the upper limit of normal, and or
- Characteristic findings from abdominal imaging (i.e. demonstrating pancreatic edema, peripancreatic fat stranding or complications or acute pancreatitis)
You may not qualify if:
- Known or newly diagnosed chronic pancreatitis based on cross sectional imaging findings
- History of gastric or pancreatic resection
- History of small bowel disease (celiac disease, or Crohn's disease)
- History of pancreatic malignancy
- History of gastroparesis
- History of cystic fibrosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio State Universitylead
- AbbViecollaborator
Study Sites (3)
Johns Hopkins Medical Institutions
Baltimore, Maryland, 21225, United States
The Ohio State University
Columbus, Ohio, 43210, United States
UPMC Presbyterian
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (4)
Bejjani J, Culp S, Nikahd M, Phillips AE, Singh V, Roberts KM, Abu-El-Haija M, Krishna SG, Ramsey ML, Lahooti A, Lee PJ, Hart PA, Papachristou GI. Symptom Burden After Acute Pancreatitis and Its Correlation With Exocrine Pancreatic Function: A Multicenter Prospective Study. Clin Transl Gastroenterol. 2025 Feb 1;16(2):e00799. doi: 10.14309/ctg.0000000000000799.
PMID: 39679584DERIVEDPhillips AE, Bejjani J, Culp S, Chennat J, Lee PJ, Machicado JD, Singh VK, Afghani E, Ramsey ML, Paragomi P, Stello K, Nikahd M, Hart PA, Papachristou GI. Prevalence of exocrine pancreatic insufficiency at 12 months after acute pancreatitis: a prospective, multicentre, longitudinal cohort study. EClinicalMedicine. 2024 Aug 2;75:102774. doi: 10.1016/j.eclinm.2024.102774. eCollection 2024 Sep.
PMID: 39210941DERIVEDBejjani J, Papachristou GI, Dungan K, Evans Phillips A, Singh V, Toledo FG, Han S, Krishna SG, Lahooti A, Lee PJ, Machicado JD, Nikahd M, Paragomi P, Ramsey M, Yadav D, Culp S, Hart PA. Incident diabetes following acute pancreatitis in a multicenter prospective observational cohort. Pancreatology. 2023 Dec;23(8):900-903. doi: 10.1016/j.pan.2023.10.009. Epub 2023 Oct 10.
PMID: 37839923DERIVEDParagomi P, Phillips AE, Machicado JD, Lahooti A, Kamal A, Afghani E, Pothoulakis I, Reynolds SL, Mays M, Conwell DL, Lara LF, Singh VK, Papachristou GI. Post-Acute Pancreatitis Pancreatic Exocrine Insufficiency: Rationale and Methodology of a Prospective, Observational, Multicenter Cohort Study. Pancreas. 2021 Feb 1;50(2):147-152. doi: 10.1097/MPA.0000000000001743.
PMID: 33565790DERIVED
Biospecimen
Blood and fecal samples will be collected for future Pancreatitis studies concerning EPI or genetics.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georgios I Papachristou, MD
Ohio State University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 2, 2017
First Posted
February 24, 2017
Study Start
June 21, 2017
Primary Completion
February 1, 2023
Study Completion
June 30, 2024
Last Updated
July 16, 2024
Record last verified: 2024-07